Page last updated: 2024-09-05

erlotinib hydrochloride and acrolein

erlotinib hydrochloride has been researched along with acrolein in 1 studies

Compound Research Comparison

Studies (erlotinib hydrochloride)	Trials (erlotinib hydrochloride)	Recent Studies (post-2010) (erlotinib hydrochloride)	Studies (acrolein)	Trials (acrolein)	Recent Studies (post-2010) (acrolein)
4,353	786	3,033	3,386	48	1,636

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Atkinson, JJ; Borchers, MT; Deshmukh, HS; Di, PY; Dietsch, M; Hardie, WD; Korfhagen, TR; Leikauf, GD; Liu, Y; McLachlan, A; Wesselkamper, SC	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and acrolein

Article	Year
Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production. American journal of respiratory and critical care medicine, 2009, Nov-01, Volume: 180, Issue:9 Topics: Acrolein; Animals; Enzyme Activation; Epithelial Cells; Erlotinib Hydrochloride; Gene Expression Regulation, Enzymologic; Humans; Lung; Matrix Metalloproteinase 14; Mice; Mucins; Protein Kinase Inhibitors; Pulmonary Disease, Chronic Obstructive; Quinazolines; Respiratory Mucosa	2009

Article

Year

Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production.

American journal of respiratory and critical care medicine, 2009, Nov-01, Volume: 180, Issue:9

Topics: Acrolein; Animals; Enzyme Activation; Epithelial Cells; Erlotinib Hydrochloride; Gene Expression Regulation, Enzymologic; Humans; Lung; Matrix Metalloproteinase 14; Mice; Mucins; Protein Kinase Inhibitors; Pulmonary Disease, Chronic Obstructive; Quinazolines; Respiratory Mucosa

2009